FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

The Marriott Inn and Conference Center, University of Maryland University College (UMUC) 

Potomac Ballroom, 3501 University Blvd. East, Hyattsville, Maryland 

 

April 1, 2014 

MEETING ROSTER 

 

Ed J. Hendricks, MD 
Medical Director  
Center for Weight Management  
Roseville, CA 
 

 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Karen Abraham-Burrell, PharmD  
Division of Advisory Committee and Consultant Management 
Office of Executive Programs 
Center for Drug Evaluation and Research 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 
                                                                                                  
Erica H. Brittain, PhD 
Mathematical Statistician 
Biostatistics Research Branch 
National Institute of Allergy and Infectious 
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, MD 
  
David W. Cooke, MD 
Associate Professor of Pediatrics 
Clinical Director, Division of Pediatric 
Endocrinology 
Director, Pediatric Endocrine Fellowship Training 
Program  
Johns Hopkins University School of Medicine 
Baltimore, MD 
 
Diana Hallare, MPH (Consumer Representative) 
Visalia, California 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER (Non-
Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Project Vice President 
GLP-1 and Obesity â€“ Global Development 
Novo Nordisk A/S.  
Denmark 
 
 

Robert J. Smith, MD (Acting Chairperson) 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
Ocean State Research Institute 
Providence Veterans Administration Medical 
Center 
Providence, RI 
 

 

Page 1 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

 

 

April 1, 2014 

MEETING ROSTER (cont.) 

 

 
TEMPORARY MEMBERS (Voting) 
 
William J. Calhoun, MD FACP FCCP 
FAAAAI  FACAAI 
Henry Renfert Jr MD Distinguished Professor in 
Internal Medicine 
Vice Chair for Research 
University of Texas Medical Branch 
Galveston, TX   
 
Katherine Flegal, PhD 
Senior Scientist and Distinguished Consultant 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Hyattsville, MD 

Rebecca W. Killion 
(Patient Representative)  
Director of Professional Development 
McKenna Long & Aldridge LLP 
Washington, DC  
 

Morris Schambelan, MD 
Professor Emeritus of Medicine 
University of California San Francisco  
San Francisco, CA 
 
James K. Stoller, M.D., M.S. 
Chair, Education Institute 
Cleveland Clinic Foundation 
Cleveland, OH   
 

 
 
 

Erik R. Swenson, MD 
Professor of Medicine and Physiology 
University of Washington 
Seattle, WA 

Eva Szabo, MD 
Chief 
Lung and Upper Aerodigestive Cancer Research 
Group, Division of Cancer Prevention 
National Cancer Institute (NCI), NIH 
Bethesda, MD              
                       
Abraham Thomas, MD, MPH, FACP 
Division Head 
Endocrinology, Diabetes, Bone & Mineral 
Disorders 
Whitehouse Chair in Endocrinology 
Henry Ford Hospital 
Detroit, MI 
 
Peter W. F. Wilson, MD 
Professor of Medicine 
Emory University School of Medicine 
Atlanta, GA 

Antoinette J. Wozniak, M.D., F.A.C.P. 
Professor of Oncology and Medicine 
Co-Director, Division of Hematology/Oncology  
Department of Oncology 
Karmanos Cancer Institute 
Detroit, MI  
 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

 

 

April 1, 2014 

MEETING ROSTER (cont.) 

 

FDA PARTICIPANTS (Non-Voting) 
 
Mary Parks, MD 
Deputy Director 
Office of Drug Evaluation II (ODE-II) 
Office of New Drugs (OND), CDER, FDA 
 

Jean-Marc Guettier, MD, CM 
Director (Acting) 
Division of Metabolism and Endocrinology 
Products (DMEP), ODE-II, OND, CDER, FDA 
 
Lokesh Jain, PhD  
Clinical Pharmacology, Team Leader 
Division of Clinical Pharmacology II 
Office of Clinical Pharmacology (OCP) 
Office of Translational Sciences (OTS) 
CDER, FDA 
 

 
 
 
 

 
 
Miya Okada Paterniti, MD  
Clinical Reviewer 
Division of Pulmonary, Allergy and 
Rheumatology Products (DPARP) 
ODE-II, OND, CDER, FDA  
 
Lisa B. Yanoff, MD  
Clinical Reviewer 
DMEP, ODE II, CDER, FDA 
 

 

 

Page 3 of 3 

